Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: The HELLO trial

Acta Neurochirurgica

Volumn 154, Issue 2, 2012, Pages 229-235

  Bähr, Oliver ^a   Hermisson, Mirjam ^b,c   Rona, Sabine ^b   Rieger, Johannes ^a   Nussbaum, Susanne ^a   Körtvelyessy, Peter ^b   Franz, Kea ^a   Tatagiba, Marcos ^b   Seifert, Volker ^a   Weller, Michael ^b,d   Steinbach, Joachim P ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Levetiracetam; Neurosurgery; Primary brain tumor; Seizures

Indexed keywords

ETIRACETAM;

ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPIDURAL HEMATOMA; EVENING DOSAGE; FEASIBILITY STUDY; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MEMORY DISORDER; MENINGIOMA; MORNING DOSAGE; NEUROSURGERY; NYSTAGMUS; OUTCOME ASSESSMENT; PARESTHESIA; PERIOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIMARY TUMOR; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOMATIC EPILEPSY; TREATMENT DURATION; TREATMENT PLANNING; VISUAL FIELD DEFECT;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICONVULSANTS; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; ELECTROENCEPHALOGRAPHY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MENINGIOMA; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEUROSURGERY; NEUROSURGICAL PROCEDURES; PILOT PROJECTS; PIRACETAM; PROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856763580     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-011-1144-9     Document Type: Article

References (30)

1. M Baulac MJ Brodie CE Elger K Krakow A Stockis P Meyvisch U Falter 2007 Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures Epilepsia 48 589 592 17326794 10.1111/j.1528-1167. 2006.00959.x 1:CAS:528:DC%2BD2sXksVaktbg%3D (Pubitemid 46365188)
2. A Beaumont IR Whittle 2000 The pathogenesis of tumour associated epilepsy Acta Neurochir (Wien) 142 1 15 10.1007/s007010050001 1:STN:280: DC%2BD3c7ivFeksA%3D%3D (Pubitemid 30068270)
3. Dinapoli L, Maschio M, Jandolo B, Fabi A, Pace A, Sperati F, Muti P (2009) Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study. Neurol Sci
4. MJ Glantz BF Cole PA Forsyth LD Recht PY Wen MC Chamberlain SA Grossman JG Cairncross 2000 Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the quality standards subcommittee of the American Academy of Neurology Neurology 54 1886 1893 10822423 1:STN:280:DC%2BD3c3osVWhsA%3D%3D (Pubitemid 30327107)
5. SL Hwang CL Lin KS Lee AS Lieu TH Kuo CZ Chang CP Yen CK Lin JK Loh TY Huang SL Howng 2004 Factors influencing seizures in adult patients with supratentorial astrocytic tumors Acta Neurochir (Wien) 146 589 594 10.1007/s00701-004-0266-8 discussion 594 (Pubitemid 38788795)
6. DA Lim P Tarapore E Chang M Burt L Chakalian N Barbaro S Chang KR Lamborn MW McDermott 2009 Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study J Neurooncol 93 349 354 19169651 10.1007/s11060-008-9781-4 1:CAS:528:DC%2BD1MXmsVClsb4%3D
7. M Maschio L Dinapoli A Zarabia B Jandolo 2006 Issues related to the pharmacological management of patients with brain tumours and epilepsy Funct Neurol 21 15 19 16734997 (Pubitemid 43985840)
8. HJ Meencke S Buyle 2006 Assessment of a dose-response relationship of levetiracetam Eur J Neurol 13 942 946 16930358 10.1111/j.1468-1331.2006.01381.x (Pubitemid 44284899)
9. RT Merrell SK Anderson FB Meyer DH Lachance 2010 Seizures in patients with glioma treated with phenytoin and levetiracetam J Neurosurg 113 1176 1181 20560728 10.3171/2010.5.JNS091367 1:CAS:528:DC%2BC3cXhs1ansrvK
10. TA Milligan S Hurwitz EB Bromfield 2008 Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery Neurology 71 665 669 18725591 10.1212/01.wnl.0000324624.52935.46 1:CAS:528: DC%2BD1cXpvFygtbw%3D
11. PL Moots RJ Maciunas DR Eisert RA Parker K Laporte B Abou-Khalil 1995 The course of seizure disorders in patients with malignant gliomas Arch Neurol 52 717 724 7619029 10.1001/archneur.1995.00540310091021 1:STN:280: DyaK2MzksVensg%3D%3D
12. W Nasreddine A Beydoun 2008 Valproate-induced thrombocytopenia: a prospective monotherapy study Epilepsia 49 438 445 18031547 10.1111/j.1528-1167. 2007.01429.x 1:CAS:528:DC%2BD1cXktVOjsLg%3D (Pubitemid 351294539)
13. S Oberndorfer T Schmal H Lahrmann S Urbanits K Lindner W Grisold 2002 The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna Wien Klin Wochenschr 114 911 916 12528323 (Pubitemid 35453292)
14. A Pace L Bove P Innocenti A Pietrangeli CM Carapella P Oppido L Raus E Occhipinti B Jandolo 1998 Epilepsy and gliomas: incidence and treatment in 119 patients J Exp Clin Cancer Res 17 479 482 10089071 1:STN:280: DyaK1M7os12gsA%3D%3D (Pubitemid 29083423)
15. E Perucca 2006 Clinically relevant drug interactions with antiepileptic drugs Br J Clin Pharmacol 61 246 255 16487217 10.1111/j.1365-2125.2005.02529.x 1:CAS:528:DC%2BD28XislKhsLs%3D (Pubitemid 43382623)
16. S Ramael A Daoust C Otoul N Toublanc M Troenaru ZS Lu A Stockis 2006 Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study Epilepsia 47 1128 1135 16886975 10.1111/j.1528-1167.2006. 00586.x 1:CAS:528:DC%2BD28XpsFeitro%3D (Pubitemid 44086747)
17. S Ramael F De Smedt N Toublanc C Otoul P Boulanger JM Riethuisen A Stockis 2006 Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects Clin Ther 28 734 744 16861095 10.1016/j.clinthera.2006.05.004 1:CAS:528:DC%2BD28Xms1Sisbk%3D (Pubitemid 44067259)
18. A Rosati L Buttolo R Stefini A Todeschini M Cenzato A Padovani 2010 Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study Arch Neurol 67 343 346 20212232 10.1001/archneurol.2009.335
19. B Schaller SJ Ruegg 2003 Brain tumor and seizures: pathophysiology and its implications for treatment revisited Epilepsia 44 1223 1232 12919395 10.1046/j.1528-1157.2003.05203.x (Pubitemid 37100049)
20. MR Sperling J Ko 2006 Seizures and brain tumors Semin Oncol 33 333 341 16769422 10.1053/j.seminoncol.2006.03.009 (Pubitemid 43849932)
21. A Stockis N Toublanc S Ramael F De Smedt C Otou P Boulanger JM Riethuisen 2005 Safety, tolerability and pharmacokinetics of levetiracetam intravenous infusion Eur J Neurol 12 37 300 10.1111/j.1468-1331.2005.01308.x
22. JB Usery LM Michael 2nd AK Sills CK Finch 2010 A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures J Neurooncol 99 251 260 20146087 10.1007/s11060-010-0126-8
23. MS van Breemen RM Rijsman MJ Taphoorn R Walchenbach H Zwinkels CJ Vecht 2009 Efficacy of anti-epileptic drugs in patients with gliomas and seizures J Neurol 256 1519 1526 19434440 10.1007/s00415-009-5156-9
24. MS van Breemen CJ Vecht 2005 Optimal seizure management in brain tumor patients Curr Neurol Neurosci Rep 5 207 213 15865886 10.1007/s11910-005-0048-6 (Pubitemid 40873036)
25. MS van Breemen EB Wilms CJ Vecht 2007 Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management Lancet Neurol 6 421 430 17434097 10.1016/S1474-4422(07)70103-5 (Pubitemid 46551867)
26. CJ Vecht M van Breemen 2006 Optimizing therapy of seizures in patients with brain tumors Neurology 67 S10 S13 17190914
27. CJ Vecht GL Wagner EB Wilms 2003 Interactions between antiepileptic and chemotherapeutic drugs Lancet Neurol 2 404 409 12849118 10.1016/S1474-4422(03) 00435-6 1:CAS:528:DC%2BD3sXms1yhsLk%3D (Pubitemid 36793932)
28. CJ Vecht GL Wagner EB Wilms 2003 Treating seizures in patients with brain tumors: drug interactions between antiepileptic and chemotherapeutic agents Semin Oncol 30 49 52 14765386 10.1053/j.seminoncol.2003.11.030 1:CAS:528:DC%2BD2cXitVKrt7w%3D (Pubitemid 38199165)
29. W Wick O Menn C Meisner J Steinbach M Hermisson M Tatagiba M Weller 2005 Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28 391 396 16160401 10.1159/000086375 1:CAS:528: DC%2BD2MXhtVahurzM (Pubitemid 41558255)
30. I Zachenhofer M Donat S Oberndorfer K Roessler 2011 Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery J Neurooncol 101 101 106 20526797 10.1007/s11060-010-0235-4 1:CAS:528: DC%2BC3cXhsFWqsbrP